Cohen Yuval insider trades
Cohen Yuval has filed 14 Form 4s with the SEC that we hold, all for Corbus Pharmaceuticals Holdings, Inc. (CRBP), as Chief Executive Officer, Director. Across all of them we count 3 purchases worth $6.8K and 13 sales worth $3.8M reported on Form 4. In the last 12 months: 0 purchases ($0) and 4 sales ($750.5K). The largest single trade was a sale of 16,830 shares of Corbus Pharmaceuticals Holdings, Inc. worth $844.4K, dated 2024-06-14. The first filing on our record is dated 2022-02-02 and the latest 2026-08-10.
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-03-09 | P, purchase reported on Form 4 | 8,600 | $3.2K | 2022-03-09 |
| 2022-05-16 | P, purchase reported on Form 4 | 10,500 | $2.6K | 2022-05-16 |
| 2022-08-10 | P, purchase reported on Form 4 | 3,800 | $988 | 2022-08-11 |
| 2024-06-14 | S, sale reported on Form 4 | 12,487 | $626.5K | 2024-06-18 |
| 2024-06-14 | S, sale reported on Form 4 | 16,830 | $844.4K | 2024-06-18 |
| 2024-06-17 | S, sale reported on Form 4 | 9,333 | $429.5K | 2024-06-18 |
| 2024-06-17 | S, sale reported on Form 4 | 1,770 | $81.5K | 2024-06-18 |
| 2024-06-18 | S, sale reported on Form 4 | 11,667 | $492.8K | 2024-06-18 |
| 2024-06-18 | S, sale reported on Form 4 | 2,322 | $98.1K | 2024-06-18 |
| 2024-06-18 | S, sale reported on Form 4 | 1,770 | $74.8K | 2024-06-18 |
| 2024-06-18 | S, sale reported on Form 4 | 7,179 | $303.2K | 2024-06-18 |
| 2025-02-14 | S, sale reported on Form 4 | 7,134 | $62.5K | 2025-02-18 |
| 2025-10-24 | S, sale reported on Form 4 | 18,660 | $317.4K | 2025-10-27 |
| 2025-10-27 | S, sale reported on Form 4 | 8,973 | $153.8K | 2025-10-27 |
| 2026-02-13 | S, sale reported on Form 4 | 13,871 | $107.9K | 2026-02-18 |
| 2026-08-07 | S, sale reported on Form 4 | 17,000 | $171.4K | 2026-08-10 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1626003) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms